Merck KGaA awarded €121 million to build lateral flow membrane facility in Wisconsin, USA
The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness






































